Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.410
+0.090 (6.82%)
At close: Apr 6, 2026, 4:00 PM EDT
1.400
-0.010 (-0.71%)
Pre-market: Apr 7, 2026, 4:00 AM EDT

Marker Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3.556.593.319.011.24
Revenue Growth (YoY)
-46.19%99.06%-63.27%625.90%166.01%
Gross Profit
3.556.593.319.011.24
Selling, General & Admin
4.184.247.4812.8212.92
Research & Development
11.813.4710.4226.1427.79
Other Operating Expenses
0.45----
Total Operating Expenses
16.4417.7117.8938.9640.72
Operating Income
-12.89-11.12-14.58-29.95-39.48
Interest Income
0.590.440.540.250.01
Other Non-Operating Income (Expense)
0.12---0.23-2.41
Total Non-Operating Income (Expense)
0.710.440.540.02-2.4
Pretax Income
-12.18-10.68-14.04-29.93-41.88
Provision for Income Taxes
-0.020.050--
Net Income
-12.16-10.73-8.24-29.93-41.88
Earnings From Discontinued Operations
--11.62--
Net Income to Common
-12.16-10.73-8.24-29.93-41.88
Shares Outstanding (Basic)
159988
Shares Outstanding (Diluted)
159988
Shares Change (YoY)
70.49%1.94%5.49%9.16%62.64%
EPS (Basic)
-0.79-1.19-0.94-3.58-5.47
EPS (Diluted)
-0.79-1.19-0.94-3.58-5.47
Shares Outstanding
16.6710.718.898.48.3
Free Cash Flow
-12.01-10.91-16.44-31.92-30.41
Free Cash Flow Per Share
-0.78-1.21-1.87-3.82-3.97
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-363.45%-168.69%-440.37%-332.23%-3179.32%
Profit Margin
-342.96%-162.82%-424.20%-332.06%-3372.68%
FCF Margin
-338.74%-165.53%-496.51%-354.10%-2449.11%
EBITDA
-12.89-11.12-14.58-26.27-36.32
EBITDA Margin
-363.45%-168.69%-440.37%-291.40%-2924.62%
EBIT
-12.89-11.12-14.58-29.95-39.48
EBIT Margin
-363.45%-168.69%-440.37%-332.23%-3179.32%
Effective Tax Rate
0.12%-0.47%-0.03%0.00%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q